Pfizer just gave up on Alzheimer and Parkinson Research
Pfizer just gave up on Alzheimer and Parkinson Research
Pharmaceutical research just received a major setback, when Pfizer, the third largest drug maker in the world, announced that they would abandon research to develop new drugs for Alzheimer’s and Parkinson’s disease. This would not only lead to job losses for those in research positions in the company, but it would also dash the hopes of those millions suffering from these dreadful conditions who were hoping for more efficient drugs. This might trigger a series of similar reactions from other companies involved in neuroscience pharmaceutical research since as put by Matthew Norton, Director of Alzhimer’s Research, ‘Neuroscience research is high risk, in that failure for pharmaceutical companies comes at a high price.’

Read full story: https://www.sciencealert.com/